Lannett Company, Inc. (NYSE:LCI)

CAPS Rating: 2 out of 5

The Company develops, manufactures, markets and distributes generic versions of pharmaceutical products.

Recs

0
Player Avatar xaneti (71.24) Submitted: 1/18/2013 5:52:53 PM : Outperform Start Price: $5.90 LCI Score: +439.49

charles schwab screener A+ Pharma Generic low PEG < 1

Featured Broker Partners


Advertisement